Vistin Pharma — Director's Dealing 2025

May 6, 2025

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Ferncliff Listed Dai AS
2	Reason for the notification
a)	Position/status	Closely associated with board member Øystein Stray Spetalen
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Vistin Pharma ASA
b)	LEI	5967007LIEEXZXFQY092
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	—Shares of Vistin Pharma ASA, isin NO0010734122 —
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) NOK 22.5 1,234,280

d)	Aggregated information —Aggregated volume — Price	1,234,280 shares sold at NOK 22.50 per share
e)	Date of the transaction	2025-05-06
f)	Place of the transaction	Oslo Stock Exchange, MIC: XOSL